Real-life patterns of use, safety and effectiveness of sunitinib in first-line therapy of metastatic renal cell carcinoma: the SANTORIN cohort study

Author:

Noize Pernelle123ORCID,Grelaud Angela1,Bay Jacques-Olivier4,Chevreau Christine5,Gross-Goupil Marine2,Culine Stéphane6,Ferrière Jean-Marie27,Moulin Flore27,Robinson Philip1,Balestra Aurelie1,Lamarque Stéphanie1,Bernard Marie-Agnès1,Lassalle Régis1,Rouyer Magali1,Droz-Perroteau Cécile1,Moore Nicholas1237ORCID,Fourrier-Réglat Annie1237,Ravaud Alain27

Affiliation:

1. Bordeaux PharmacoEpi; Inserm CIC1401; Bordeaux France

2. CHU Bordeaux; Bordeaux France

3. Bordeaux Population Health Research Centre, Pharmacoepidemiology team; Inserm U1219; Bordeaux France

4. CHU Clermont-Ferrand; Site Estaing et Centre Jean Perrin; Clermont-Ferrand France

5. Institut Claudius Regaud; Toulouse France

6. Hôpital Saint-Louis; Paris France

7. University Bordeaux; Bordeaux France

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference33 articles.

1. Ferlay J Soerjomataram I Ervik M , et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 http://globocan.iarc.fr

2. Renal-cell carcinoma;Motzer;N Engl J Med,1996

3. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy;Ljungberg;Curr Urol Rep,2013

4. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2004

5. Novel agents and approaches for advanced renal cell carcinoma;Figlin;J Urol,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3